Almost every other Coronavirus-related news has been about how the number of positive cases is increasing across various parts of the world. But today, we have some positive news straight from the journal, Nature Communications.
It looks like scientists have created a monoclonal antibody that can defeat the new Coronavirus in the lab. It’s an early but promising step towards finding a potential cure for the virus and curb its spread.
So, we’re looking at an experimental antibody that has neutralized the virus in cell cultures. It’s called 47D11 and it managed to prevent COVID-19 and SARS in the study.
Does it mean we finally have a cure? Well, not exactly, but there’s a lot of potential.
This particular antibody is early in the stage of development, which means there’s still a lot of tests that need to be done. If everything goes according to plan, then it’ll be tested on animals before it enters the human trials.
According to the study published in the journal, Nature Communications, the antibody may help prevent or treat COVID-19 or other related diseases in the future.
However, it remains to be seen whether it can do it alone by itself or in a drug combination.
During the lab tests, the antibody managed to not only kill the virus responsible for COVID-19 but also a cousin equipped with similar spike proteins that can cause SARS.
These Monoclonal antibodies already sparked a treatment revolution in cancer. Similar antibodies have also shown promising results against Ebola, so it’ll be interesting to see what comes out of this.